Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Gastrointestinal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05241899
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer

Who this might be right for
Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 56
Not applicableStudy completedNCT05684432
What this trial is testing

Radiation-induced Diarrhoea During Curative EBRT of Prostate and Rectal Cancer

Who this might be right for
Radiation-induced Diarrhoea in Prostate and Rectal Cancer
Aalborg University Hospital 40
Not applicableWithdrawnNCT05418387
What this trial is testing

A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona

Who this might be right for
Renal Cell CarcinomaHepatocellular Carcinoma
University of Arizona
Testing effectiveness (Phase 2)Study completedNCT01941316
What this trial is testing

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers
Cancer Research and Biostatistics Clinical Trials Consortium 78
Testing effectiveness (Phase 2)WithdrawnNCT03991104
What this trial is testing

SOX-based CRT for Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Zhejiang Provincial People's Hospital
Testing effectiveness (Phase 2)UnknownNCT04893252
What this trial is testing

Vactosertib and Durvalumab in Gastric Cancer

Who this might be right for
Stomach Neoplasm
Hark Kyun Kim 55
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Large-scale testing (Phase 3)UnknownNCT02381847
What this trial is testing

Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients

Who this might be right for
Malignant Neoplasm of Stomach
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Testing effectiveness (Phase 2)Study completedNCT00002955
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Southern California 21
Not applicableEnded earlyNCT03385343
What this trial is testing

Staging of Superficial EAC Using VLE

Who this might be right for
Esophageal Cancer
Mayo Clinic 30
Post-approval studies (Phase 4)Ended earlyNCT06077487
What this trial is testing

Ketamine-assisted Therapy for Advanced GI Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPain, AcuteGastrointestinal Cancers+1 more
Brian Anderson, MD 1
Large-scale testing (Phase 3)Looking for participantsNCT06296706
What this trial is testing

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 630
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Post-approval studies (Phase 4)Study completedNCT00488904
What this trial is testing

Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery

Who this might be right for
Colorectal Cancer
Aalborg University Hospital 148
Testing effectiveness (Phase 2)Study completedNCT01138904
What this trial is testing

FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Cancer
Dong-A University Hospital 80
Not applicableUnknownNCT05077358
What this trial is testing

Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection

Who this might be right for
Adenocarcinoma of the Colon
Yonsei University 241
Not applicableStudy completedNCT01693848
What this trial is testing

"Cancersensor" Metastasis Resection

Who this might be right for
Metastatic Colorectal Cancer
Institut National de la Santé Et de la Recherche Médicale, France 10
Not applicableUnknownNCT06115655
What this trial is testing

A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles

Who this might be right for
Bile Duct NeoplasmsJaundice, ObstructiveBile Duct Diseases
Air Force Military Medical University, China 161
Not applicableStudy completedNCT00792285
What this trial is testing

RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening

Who this might be right for
Colorectal Cancer
Harvard Pilgrim Health Care 80,000
Next Page